Advanced search
Publication Cover
Leukemia & Lymphoma Volume 40, 2001 - Issue 5-6
Submit an article Journal homepage
111
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Cost-Effectiveness of Interferon Alfa-2b Added to Chemotherapy for High-Tumor-Burden Follicular Non-Hodgkin's Lymphoma

Daniel P. Wirt Baylor College of Medicine, Houston
,
Francis J. Giles M.D. Anderson Cancer Center, Houston, TexasCorrespondence[email protected]
,
Martin M. Oken Virginia “Paper” Cancer Institute Minneapolis, Minnesota, Texas, USA
,
Philippe Solal-Celigny Groupe d'Etude des Lymphomes Folliculaires (GELF), Paris, France
&
J. Robert Beck Baylor College of Medicine, Houston
Pages 565-579 | Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

M. C. Cheung, A. Prica, J. Graczyk, R. Buckstein & K. K. W. Chan. (2016) Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis. Leukemia & Lymphoma 57:8, pages 1865-1875.
Read now
Michel van Agthoven, Carin A Uyl-de Groot, Pieter Sonneveld & Anton Hagenbeek. (2004) Economic assessment in the management of non-Hodgkin’s lymphoma. Expert Opinion on Pharmacotherapy 5:12, pages 2529-2548.
Read now

Articles from other publishers (14)

Jagpreet Chhatwal, Michael Mathisen & Hagop Kantarjian. (2015) Are high drug prices for hematologic malignancies justified? A critical analysis. Cancer 121:19, pages 3372-3379.
Crossref
Patricia Cerrito. 2012. Encyclopedia of Biopharmaceutical Statistics, Third Edition. Encyclopedia of Biopharmaceutical Statistics, Third Edition 663 667 .
Shein-Chung ChowPatricia B. Cerrito. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics 663 667 .
Rebecca L. Olin, Peter A. Kanetsky, Thomas R. Ten Have, Sunita D. Nasta, Stephen J. Schuster & Charalambos Andreadis. (2010) Determinants of the optimal first‐line therapy for follicular lymphoma: A decision analysis. American Journal of Hematology 85:4, pages 255-260.
Crossref
Paolo Baldo, Maurizio Rupolo, Anna Compagnoni, Renzo Lazzarini, Alessandra Bearz, Renato Cannizzaro, Simon Spazzapan, Ivana Truccolo & Lorenzo Moja. (2010) Interferon-alpha for maintenance of follicular lymphoma. Cochrane Database of Systematic Reviews.
Crossref
Talia Foster, Jeffrey D. Miller, Mark E. Boye & Mason W. Russell. (2009) Economic Burden of Follicular Non-Hodgkinʼs Lymphoma. PharmacoEconomics 27:8, pages 657-679.
Crossref
Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Donald P. Tashkin & Mark H. Eckman. (2008) Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision Analysis. Medical Decision Making 28:6, pages 926-937.
Crossref
Patricia Marino, Henri Roché & Jean-Paul Moatti. (2008) High-Dose Chemotherapy for Patients With High-Risk Breast Cancer. American Journal of Clinical Oncology 31:2, pages 117-124.
Crossref
Dennis A. Revicki, David Feeny, Timothy L. Hunt & Bernard F. Cole. (2006) Analyzing Oncology Clinical Trial Data Using the Q-TWiST Method: Clinical Importance and Sources for Health State Preference Data*. Quality of Life Research 15:3, pages 411-423.
Crossref
Mark C. Hornbrook. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer 480 502 .
Paolo Baldo, Alessandra Bearz, Renato Cannizzaro, Vincenzo Canzonieri, Luigino Dal Maso, Vincenzo Di Lauro, Renzo Lazzarini, Isabella Milan, Maurizio Rupolo, Simona Scalone, Simon Spazzapan, Giuseppe Toffoli, Ivana Truccolo & Antonino Carbone. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Patricia Cerrito. 2003. Encyclopedia of Biopharmaceutical Statistics, Second edition. Encyclopedia of Biopharmaceutical Statistics, Second edition 512 517 .
Susana Clemente Bautista, Luís Mendante Barrenechea & José Bruno Montoro Ronsano. (2003) Marco actual de los productos biotecnológicos según los estudios farmacoeconómicos disponibles. Medicina Clínica 120:13, pages 498-504.
Crossref
. (2001) Current Awareness in Hematological Oncology. Hematological Oncology 19:4, pages 159-166.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.